Prospective Study on the Diagnostic Efficacy of Early Gastric Cancer Using a New Thin Scope for EG-840TP

Prospective Study on the Diagnostic Efficacy of Early Gastric Cancer Using a New Thin Scope for EG-840TP - Prospective Study on the Diagnostic Efficacy of Early Gastric Cancer Using a New Thin Scope for EG-840TP

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000053420

Enrollment

175

Registered

2024-01-31

Start date

2024-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early gastric cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing endoscopic submucosal dissection (ESD) for early gastric cancer or suspected early gastric cancer. Consent to participate in the study was obtained on paper. Over 18 years old.

Exclusion criteria

Exclusion criteria: Postoperative stomach. Patients with multiple epithelial tumors (including suspected lesions) Patients who are judged to be inappropriate for this study by the principal investigator or subcontractor. Patients allergic to propofol, pentazocine, and lidocaine. Patients who are pregnant or breastfeeding.

Design outcomes

Primary

Measure	Time frame
Diagnosis results of Trainee and Expert	—

Countries

Japan

Contacts

Public ContactTomohiro shimada

Sendai City Medical Center Department of Gastroenterology

t.shimada@openhp.or.jp09067892904

Outcome results